Results 231 to 240 of about 358,941 (349)
ABSTRACT Background Suppression of the peroxisome proliferator‐activated receptor alpha (PPARα) has been related to poor outcomes in sepsis and may compromise ketogenesis during critical illness. Infusion of 3‐hydroxybutyrate (3HB) was shown to attenuate muscle weakness in septic mice.
Caroline Lauwers +12 more
wiley +1 more source
A novel MRI diffusion metric 'slow diffusion coefficient' (SDC) for diagnosing isocitrate dehydrogenase (IDH) genotype in diffuse gliomas: initial promising results. [PDF]
Zheng WY +6 more
europepmc +1 more source
Isocitrate dehydrogenase‐mutant glioma: Evolving clinical and therapeutic implications
Julie J. Miller +3 more
semanticscholar +1 more source
Systematic media optimization in Amycolatopsis orientalis identified maltodextrin, soy‐based nitrogen sources, and phosphate regulation as key drivers of vancomycin yield. Knockout and feeding trials demonstrated essential nutrient roles, offering a cost‐effective, scalable strategy for enhanced antibiotic production.
Vineeth Mani +2 more
wiley +1 more source
Transcriptomic Profile of Isocitrate Dehydrogenase Mutant Type of Lower-Grade Glioma Reveals Molecular Changes for Prognosis. [PDF]
Cho SB.
europepmc +1 more source
Protein arginine methyltransferase 1 (PRMT1) is a pivotal enzyme that catalyzes the asymmetric dimethylation of arginine residues, thereby functioning as a critical epigenetic regulator of diverse biological processes such as gene expression, RNA splicing, and DNA repair.
Yanqun Luo +4 more
wiley +1 more source
Role of the tumor board when prescribing mutant isocitrate dehydrogenase inhibitors to patients with isocitrate dehydrogenase-mutant glioma. [PDF]
Roth P +4 more
europepmc +1 more source
The role of yeast NAD+-isocitrate dehydrogenase in mitochondrial translation
S.D.J. Elzinga
openalex +1 more source

